Literature DB >> 4247823

A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.

D P Thomas, S Niewiarowski, A R Myers, K J Bloch, R W Colman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4247823     DOI： 10.1056/NEJM197009242831301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Consumption coagulopathy in a child with congenital cyanotic heart disease and its treatment with heparin.

Authors:  A S Patil; B M Sarup; S Mehta
Journal:  Indian J Pediatr       Date:  1975-01       Impact factor: 1.967

2.  The production and testing of staphylococci with clumping factor activity for use in the assay of fibrinogen degradation products.

Authors:  G Richardson
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

3.  Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.

Authors:  E Plow; T S Edgington
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

4.  A comparison of the TRCII and latex-particle tests for the titration of FR-antigen.

Authors:  C L Arocha-Piñango
Journal:  J Clin Pathol       Date:  1972-09       Impact factor: 3.411

5.  The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.

Authors:  M B Garvey; J M Black
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

6.  Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J D Cash; J S Robson
Journal:  Br Med J       Date:  1972-07-29

7.  The origin of fibrin breakdown products and the interpretation of their appearance in the circulation.

Authors:  M J Gallimore; H M Tyler; J T Shaw
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

Review 8.  Disseminated intravascular coagulation (DIC) and rhabdomyolysis in fulminant varicella infection--case report and review of the literature.

Authors:  U Hollenstein; F Thalhammer; H Burgmann
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 7.455

9.  The discovery and identification of a candidate proteomic biomarker of active tuberculosis.

Authors:  Jiyan Liu; Tingting Jiang; Liliang Wei; Xiuyun Yang; Chong Wang; Xing Zhang; Dandan Xu; Zhongliang Chen; Fuquan Yang; Ji-Cheng Li
Journal:  BMC Infect Dis       Date:  2013-10-29       Impact factor: 3.090
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.